Abstract:Berberine, a well-known alkaloid, has been proved to possess various pharmacological activities. Previous studies demonstrated that berberine could be extensively metabolized and the metabolites also contributed to its therapeutic effects. However, as for berberine’s metabolites, especially phase II metabolites, pharmacokinetics and excretion studies were rarely reported. The objective of this study was to thoroughly investigate the pharmacokinetic and excretion profiles of berberine and its nine metabolites, namely, berberrubine (M1), demethyleneberberine (M2), jatrorrhizine (M3), jatrorrhizine-3- O-β -D-glucuronide (M4), jatrorrhizine-3- O -sulfate (M5), thalfendine-10- O-β -D-glucuronide (M6), berberrubine-9- O-β -D-glucuronide (M7), demethyleneberberine-2- O -sulfate (M8) and demethyleneberberine-2- O-β -D-glucuronide (M9) in rats. An accurate and reliable LC-MS/MS method was developed and validated for the determination of berberine and its nine metabolites in rat biosamples. Pharmacokinetic profiles of berberine and its nine metabolites were obtained after a single intravenous administration (4.0 mg/kg) and oral administration (48.2, 120 or 240 mg/kg) of berberine in rats. For excretion study, rats were intragastrically administered a single dose of 48.2 mg/kg berberine. Our results showed that berberine could be metabolized rapidly and all the nine metabolites could be detected in vivo . The absolute bioavailability of berberine was 0.37 ± 0.11%. As for the AUC 0–48 h values, phase II metabolites were much higher than those of phase I metabolites, suggesting that phase II metabolites were the major metabolites exist in blood circulation. 18.6% of the berberine was excreted in feces as berberrubine (M1). The total recovery of berberine and its nine metabolites from urine, bile and feces was 41.2%. This is the first systematic study about the pharmacokinetics and excretion of berberine and its nine metabolites, which will be beneficial for both better understanding the clinical effects and further development of berberine.

Plasma and Hippocampal Pharmacokinetics of Berberine after Intravenous or Intranasal Administration in Rats

Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract.

Pharmacokinetics of berberine in rat thalamus after intravenous administration of Coptidis rhizoma extract.

Pharmacokinetics of Berberine in Rat Cerebral Nuclei Following Intravenous Administration of Coptidis Rhizoma Extract

The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats

Pharmacokinetic behavior in plasma, cerebrospinal fluid and cerebral cortex after intranasal administration of hydrochloride meptazinol.

Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats.

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats

Enhancement of Systemic and CNS Delivery of Meptazinol Hydrochloride by Intranasal Administration to Rats.

Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations

Pharmacokinetics of Berberine in Rat Intestinal and Bile Following Intravenous Administration of Coptidis Rhizoma Extract

Microdialysis Pharmacokinetic Study of Scopolamine in Plasma, Olfactory Bulb and Vestibule after Intranasal Administration

[Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats].

Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats

Characterization Of The Transportation Of Berberine In Coptidis Rhizoma Extract Through Rat Primary Cultured Cortical Neurons

Comparative pharmacokinetics of tetramethylpyrazine phosphate in rat plasma and extracellular fluid of brain after intranasal, intragastric and intravenous administration

Sensitive Analysis and Pharmacokinetic Study of Berberrubine Using LC-MS/MS

The Pharmacokinetics, Bioavailability and Excretion of Bergapten after Oral and Intravenous Administration in Rats Using High Performance Liquid Chromatography with Fluorescence Detection

Determination of Bergenin in Rat Plasma by High-Performance Liquid Chromatography.

Distribution of Nimodipine in Brain Following Intranasal Administration in Rats

In Vivo Pharmacokinetics of Puerarin via Different Drug Administration Routes Based on Middle Cerebral Artery Occlusion Model